CompletedNot Applicable

A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population

China1,200 participantsStarted 2021-09-24

Plain-language summary

This study aims to use a social media mini-application-enabled intervention to successfully promote the initiation and persistence of pre-exposure prophylaxis (PrEP) among at-risk people 18 years and above (including men who have sex with men (MSM), transgender women, sex workers, and other key populations) in Wuhan and Guangzhou, China.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18+ * Engaged in at-risk sex. At risk sex is defined as sex with \>1 partner in the past 90 days, inconsistent condom use with vaginal or anal sex, ongoing sexual relationship with an HIV-positive partner, participation in commercial sex work, or any bacterial STI diagnosed or reported in the past 6 months. Exclusion Criteria: * History renal dysfunction * Chronic hepatitis B (HBV) infection * HIV infection * Indication for HIV post-exposure prophylaxis * Signs and symptoms consistent with acute HIV infection * Under the age range of 18

What they're measuring

PrEP prescriptions

Timeframe: 2 years

Trial details

NCT IDNCT04754139

SponsorUniversity of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More HIV Preexposure Prophylaxis trials